Skip to main content
All lobbying filings

SPLITOAK STRATEGIES LLC

Lobbying for JOHNSON & JOHNSON SERVICES, INC. · Global biopharmaceutical, medical device and consumer product manufacturer.

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $50,000.00 income · posted Apr 20, 2026

Official filing document

 Lobbying activity 1
Medicare/Medicaid

Value of prescription drugs and patient access Issues related to Medicare Parts B & D, MFN Promoting U.S. competitiveness while ensuring U.S. leadership role in developing medicines

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem